Multiple Sclerosis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 18 or older.
- People who are willing to agree to participate and follow the treatments and procedures involved in the study.
- People who have been diagnosed with relapsing-remitting multiple sclerosis (a form of MS with periods of new or worsening symptoms followed by recovery) using a specific set of medical guidelines called the revised McDonald 2017 criteria.
- People who are currently taking a medication called fingolimod, as directed by its official prescribing guidelines.
- People who have at least 12 months of medical follow-up records available before joining the study, with enough detail to calculate how often relapses have occurred over time.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People under 18 years of age.
- People for whom fingolimod is not considered safe or appropriate according to its official prescribing guidelines.
- People with a history of mental illness or substance use that could affect their ability to take part in the study.
- People who are already taking part in another research study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nikolaos Grigoriadis, MD, AHEPA University Hospital of Thessaloniki, Greece
Phone: 003021011865734
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Annualized Relapse Rate, ARR
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.